News

Crop science giant Bayer says it has settled 17,000 glyphosate cases so far and hopes for a supreme court ruling next year.
Bayer has recently settled thousands of cases over claims the active ingredient in its Roundup weedkiller causes cancer, ...
The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...
A French court ruled on Thursday that a complaint brought by a family against Bayer claiming their son's disabilities were ...
Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s ...
(Reuters) -German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion ...
The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...
Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...
Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...
Bayer investor Union Investment called on Wednesday for the German company to reconsider its litigation strategy for glyphosate and a key U.S. trial lawyer signaled interest in re-starting ...
Bayer seems to be pursuing a “both/and” strategy with regard to its signature glyphosate-based pesticide Roundup. It is defending against lawsuits and attacks on glyphosate, even while it ...
July 25 (Reuters) - Further deterioration in demand for glyphosate-based weed killers led Bayer (BAYGn.DE), opens new tab to cut its full-year earnings outlook and announce a 2.5 billion euro ($2. ...